Top Markets
Coin of the day
BCAL Diagnostics Limited BCAL Diagnostics Limited

BCAL Diagnostics Limited

BDX
Classifica tra le azioni #31189
BCAL Diagnostics Limited is a biotechnology firm focused on creating an... BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
Prezzo delle azioni
$0.03808538
Capitalizzazione di mercato
$14.04M
Variazione (1 giorno)
-3.57%
Variazione (1 anno)
6.63%
Paese
AU
Scambia BCAL Diagnostics Limited (BDX)

Categoria

Storico del rendimento da dividendi per BCAL Diagnostics Limited (BDX)
Il rendimento da dividendi (TTM) di BCAL Diagnostics Limited (simbolo azionario: BDX) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per BCAL Diagnostics Limited (BDX) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti